Lymphoblastoid interferon alfa-n1 improves the long-term response to a 6-month course of treatment in chronic hepatitis C compared with recombinant interferon alfa-2b: Results of an international randomized controlled trial
(Q74428457)
scientific article published on 01 April 1998
scientific article published on 01 April 1998
Language:
other details
description | scientific article published on 01 April 1998 |
External Links
(P356) |
10.1002/HEP.510270429
|
(P698) |
9537453
|